Cibc World Markets Corp Blueprint Medicines Corp Transaction History
Cibc World Markets Corp
- $16.6 Billion
- Q4 2024
A detailed history of Cibc World Markets Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cibc World Markets Corp holds 5,950 shares of BPMC stock, worth $618,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,950Holding current value
$618,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
359Shares Held
61.3MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.68MShares$695 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$691 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$560 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$412 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$288 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...